COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: HIV-related text messaging
Behavioral: Nutrition-related text messaging

First Posted Date: 2008-01-28

Last Posted Date: 2015-04-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 103

Registration Number: NCT00601237

Locations: 🇺🇸
Motivational Educational Entertainment (MEE) Productions, Philadelphia, Pennsylvania, United States

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy

Phase 1

Completed

Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy

Interventions: Drug: ranibizumab

First Posted Date: 2007-11-21

Last Posted Date: 2016-09-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 2

Registration Number: NCT00561834

Locations: 🇺🇸
Rocky Mountain Lions Eye Institute, Aurora, Colorado, United States

Assessing Ocular Surface Changes After Changing Glaucoma Medications

Completed

Conditions: Glaucoma
Ocular Surface Disease
Monotherapy With Xalatan From 1 to 18 Months

First Posted Date: 2007-11-06

Last Posted Date: 2017-01-27

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 22

Registration Number: NCT00554411

Locations: 🇺🇸
Rocky Mountain Lions Eye Institute, Aurora, Colorado, United States

Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software

Completed

Conditions: Diabetes

Interventions: Device: Insulin Guidance Software

First Posted Date: 2007-11-02

Last Posted Date: 2015-08-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 123

Registration Number: NCT00552734

Locations: 🇺🇸
University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, Aurora, Colorado, United States

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Phase 1

Completed

Conditions: Malignant Solid Tumour
Biliary Cancer
Pancreatic Cancer

Interventions: Drug: Gemcitabine
Drug: Capecitabine
Drug: ZD6474

First Posted Date: 2007-10-30

Last Posted Date: 2013-12-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 23

Registration Number: NCT00551096

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Marketing Fall Prevention Classes to Older Adults in Faith-Based Congregations

Not Applicable

Completed

Conditions: Accidental Falls

Interventions: Behavioral: Marketing program to motivate exercise class participation

First Posted Date: 2007-10-11

Last Posted Date: 2018-12-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 51

Registration Number: NCT00542360

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸
Colorado Department of Public Health and Environment, Grand Junction, Colorado, United States

Examining Macrophage Influx and Vascularization in Chronic Pancreatitis

Completed

Conditions: Pancreatitis
Diabetes

First Posted Date: 2007-06-25

Last Posted Date: 2013-02-12

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00491023

Locations: 🇺🇸
University of Colorado Health Sciences Center, Aurora, Colorado, United States

The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Silibin-Phytosome

First Posted Date: 2007-06-19

Last Posted Date: 2014-03-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 12

Registration Number: NCT00487721

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Phase 1

Completed

Conditions: HIV Infections
Contraception
Pharmacokinetics

Interventions: Drug: levonorgestrel, efavirenz

First Posted Date: 2007-06-06

Last Posted Date: 2013-07-15

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 24

Registration Number: NCT00482963

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States

Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells

Not Applicable

Terminated

Conditions: Open Angle Glaucoma

Interventions: Drug: Acular LS
Drug: Pred Forte
Other: Refresh Tears

First Posted Date: 2007-05-24

Last Posted Date: 2016-10-07

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 31

Registration Number: NCT00478036

Locations: 🇺🇸
University of Colorado Eye Center, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy